HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ghina Alame Selected Research

Rupture

8/2011The antithrombotic activity of EP224283, a neutralizable dual factor Xa inhibitor/glycoprotein IIbIIIa antagonist, exceeds that of the coadministered parent compounds.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ghina Alame Research Topics

Disease

2Atherosclerotic Plaque (Atheroma)
02/2015 - 08/2011
2Thrombosis (Thrombus)
02/2015 - 08/2011
1Dehydration (Water Stress)
09/2015
1Hemorrhage
08/2011
1Rupture
08/2011
1Thromboembolism
08/2011

Drug/Important Bio-Agent (IBA)

2AnticoagulantsIBA
02/2015 - 08/2011
2Apolipoproteins E (ApoE)IBA
02/2015 - 08/2011
1Hemostatics (Antihemorrhagics)IBA
09/2015
1Fondaparinux (Arixtra)FDA Link
02/2015
1EP 217609IBA
02/2015
1Pharmaceutical PreparationsIBA
02/2015
1N(alpha)- (2- naphthylsulfonylglycyl)- 4- amidinophenylalanine piperidide (NAPAP)IBA
02/2015
1FIIaIBA
02/2015
1Tirofiban (Aggrastat)FDA Link
08/2011
1Factor Xa (Coagulation Factor Xa)IBA
08/2011
1ThrombinFDA Link
08/2011
1EP 224283IBA
08/2011
1AntithrombinsIBA
08/2011
1ferric chlorideIBA
08/2011